Biogen Inc (NASDAQ:BIIB)

327.10
Delayed Data
As of Jul 30
 -2.07 / -0.63%
Today’s Change
223.25
Today|||52-Week Range
468.55
+33.59%
Year-to-Date

Stock Price Forecast

The 26 analysts offering 12-month price forecasts for Biogen Inc have a median target of 428.50, with a high estimate of 647.00 and a low estimate of 244.00. The median estimate represents a +31.00% increase from the last price of 327.10.

Analyst Recommendations

The current consensus among 33 polled investment analysts is to Hold stock in Biogen Inc. This rating has held steady since July, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$4.24
Sales
$2.7B
Reporting Date
Oct 26

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -25.44%
 
 
 
 
 
 
Growthannually -44.69%
 
 
 
 
 
 

Sales

Growthquarterly -3.69%
 
 
 
 
 
 
Growthannually -20.12%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.